Bafilomycin A1

Inhibits autophagy and vacuolar H+-ATPase (V-ATPase)

产品号 #74242_C

Inhibits autophagy and vacuolar H+-ATPase (V-ATPase)

概述

Bafilomycin A1 is a macrolide antibiotic drug and autophagy inhibitor. It prevents the acidification of autophagosomes via the inhibition of vacuolar H+-ATPase (V-ATPase; Klionsky et al.).


MAINTENANCE AND SELF-RENEWAL
· Inhibits the proteolytic degradation associated with autophagy in human mesenchymal stem cells (Oliver et al.).

CANCER RESEARCH
· At low concentrations, it inhibits autophagy and promotes apoptotic cell death in pediatric B cell acute lymphoblastic leukemia (B-ALL) cells (Yuan et al.).

Cell Type
B Cells, Cancer Cells and Cell Lines, Leukemia/Lymphoma Cells, Mesenchymal Stem and Progenitor Cells
 
Species
Human, Mouse, Non-Human Primate, Other, Rat
 
Application
Maintenance
 
Area of Interest
Autophagy, Cancer, Immunology, Stem Cell Biology
 
CAS Number
88899-55-2
 
Chemical Formula
C₃₅H₅₈O₉
 
Purity
≥ 95%
 

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Product Name
Bafilomycin A1
Catalog #
74242
Lot #
All
Language
English
Document Type
Safety Data Sheet
Product Name
Bafilomycin A1
Catalog #
74242
Lot #
All
Language
English

Applications

This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.

PRODUCTS ARE FOR RESEARCH USE ONLY AND NOT INTENDED FOR HUMAN OR ANIMAL DIAGNOSTIC OR THERAPEUTIC USES UNLESS OTHERWISE STATED. FOR ADDITIONAL INFORMATION ON QUALITY AT STEMCELL, REFER TO WWW.STEMCELL.COM/COMPLIANCE.
版权 © 2025 STEMCELL Technologies 技术有限公司。保留所有权利。